These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
572 related items for PubMed ID: 10455362
1. Bone marrow transplantation for transfused patients with severe aplastic anemia using cyclophosphamide and total lymphoid irradiation as conditioning therapy: long-term follow-up from a single center. Gaziev D, Giardini C, Galimberti M, Lucarelli G, Angelucci E, Polchi P, Baronciani D, Erer B, Sotti G. Bone Marrow Transplant; 1999 Aug; 24(3):253-7. PubMed ID: 10455362 [Abstract] [Full Text] [Related]
2. Bone marrow transplantation for severe aplastic anemia: the Barcelona Hospital Clinic experience. Hernández-Boluda JC, Marín P, Carreras E, Aguilar JL, Grañena A, Rozman C, Montserrat E. Haematologica; 1999 Jan; 84(1):26-31. PubMed ID: 10091390 [Abstract] [Full Text] [Related]
3. Long-term outcome after bone marrow transplantation for aplastic anemia using cyclophosphamide and total lymphoid irradiation as conditioning regimen. Inamoto Y, Suzuki R, Kuwatsuka Y, Yasuda T, Takahashi T, Tsujimura A, Sugimoto K, Oba T, Terakura S, Atsuta Y, Murata M, Ito M, Kodera Y, Miyamura K. Biol Blood Marrow Transplant; 2008 Jan; 14(1):43-9. PubMed ID: 18158960 [Abstract] [Full Text] [Related]
4. Successful bone marrow transplantation in sensitized aplastic anemia patients using total lymphoid irradiation for conditioning: long-term follow-up. Zapatero A, Marín A, López M, Martín De Vidales C, Cerezo L, Domínguez P, Pérez Torrubia A. Hematol Oncol; 1996 Dec; 14(4):165-72. PubMed ID: 9267462 [Abstract] [Full Text] [Related]
5. Use of cyclophosphamide and total lymphoid irradiation combined with cyclosporine in bone marrow transplantation for transfused severe aplastic anemia. Miyamura K, Kojima S, Takeyama K, Matsushita T, Fukuda M, Horibe K, Minami S, Morishima Y, Matsuyama K, Kodera Y. Bone Marrow Transplant; 1988 Sep; 3(5):457-61. PubMed ID: 3056553 [Abstract] [Full Text] [Related]
6. Excellent long-term survival after allogeneic marrow transplantation in patients with severe aplastic anemia. Reiter E, Keil F, Brugger S, Kalhs P, Rabitsch W, Hinterberger W, Fischer G, Rosenmayr A, Haas O, Volc B, Lechner K, Greinix HT. Bone Marrow Transplant; 1997 Jun; 19(12):1191-6. PubMed ID: 9208112 [Abstract] [Full Text] [Related]
7. Clinical results in 50 multiply transfused patients with severe aplastic anemia treated with bone marrow transplantation or immunosuppressive therapy. Arranz R, Otero MJ, Ramos R, Steegmann JL, Lamana ML, Tomás JF, de la Cámara R, Figuera A, Vázquez L, Fernádez-Rañada JM. Bone Marrow Transplant; 1994 Apr; 13(4):383-7. PubMed ID: 8019461 [Abstract] [Full Text] [Related]
8. Long-term follow-up of allogeneic stem cell transplantation in patients with severe aplastic anemia after conditioning with cyclophosphamide plus antithymocyte globulin. Kröger N, Zabelina T, Renges H, Krüger W, Kordes U, Rischewski J, Schrum J, Horstmann M, Ayuk F, Erttmann R, Kabisch H, Zander AR. Ann Hematol; 2002 Nov; 81(11):627-31. PubMed ID: 12454700 [Abstract] [Full Text] [Related]
9. Allogeneic bone marrow transplantation for severe aplastic anemia: the Vancouver experience. Cuthbert RJ, Shepherd JD, Nantel SH, Barnett MJ, Reece DE, Klingemann HG, Chan KW, Spinelli JJ, Sutherland HJ, Phillips GL. Clin Invest Med; 1995 Apr; 18(2):122-30. PubMed ID: 7788957 [Abstract] [Full Text] [Related]
10. Favorable effect on acute and chronic graft-versus-host disease with cyclophosphamide and in vivo anti-CD52 monoclonal antibodies for marrow transplantation from HLA-identical sibling donors for acquired aplastic anemia. Gupta V, Ball SE, Yi QL, Sage D, McCann SR, Lawler M, Ortin M, Freires M, Hale G, Waldmann H, Gordon-Smith EC, Marsh JC. Biol Blood Marrow Transplant; 2004 Dec; 10(12):867-76. PubMed ID: 15570255 [Abstract] [Full Text] [Related]
11. Non-total body irradiation containing preparative regimen in alternative donor bone marrow transplantation for severe aplastic anemia. Lee JH, Choi SJ, Lee JH, Lee YS, Seol M, Ryu SG, Lee JS, Kim WK, Lee KH. Bone Marrow Transplant; 2005 Apr; 35(8):755-61. PubMed ID: 15735661 [Abstract] [Full Text] [Related]
12. BMT for severe aplastic anemia using cyclosporine. May WS, Sensenbrenner LL, Burns WH, Ambinder R, Carroll MP, Griffin CA, Jones RJ, Miller CB, Mellits ED, Vogelsang GB. Bone Marrow Transplant; 1993 Jun; 11(6):459-64. PubMed ID: 8334426 [Abstract] [Full Text] [Related]
13. Cyclophosphamide and antithymocyte globulin as a conditioning regimen for allogeneic marrow transplantation in patients with aplastic anaemia: a long-term follow-up. Kahl C, Leisenring W, Deeg HJ, Chauncey TR, Flowers ME, Martin PJ, Sanders JE, Storb R. Br J Haematol; 2005 Sep; 130(5):747-51. PubMed ID: 16115132 [Abstract] [Full Text] [Related]
14. Unrelated donor bone marrow transplants for severe aplastic anemia with conditioning using total body irradiation and cyclophosphamide. Kim SY, Lee JW, Lim J, Cho BS, Eom KS, Kim YJ, Kim HJ, Lee S, Min CK, Cho SG, Kim DW, Min WS, Kim CC. Biol Blood Marrow Transplant; 2007 Jul; 13(7):863-70. PubMed ID: 17580265 [Abstract] [Full Text] [Related]
15. [Allogeneic bone marrow transplantation in children with severe acquired aplastic anemia. The long-term results. The Spanish Group for Bone Marrow Transplantation in Children (GETMON)]. Muñoz Villa A, Ortega Aramburu JJ, Bureo Dacal E, Badell Serra I, Madero López L, Olive Oliveras T, Cubells Riero J, Maldonado Regalado MS, Ramírez Orellana M. An Esp Pediatr; 1999 Jan; 50(1):29-32. PubMed ID: 10083639 [Abstract] [Full Text] [Related]
16. CY/TBI-800 as a pretransplant regimen for allogeneic bone marrow transplantation for severe aplastic anemia using HLA-haploidentical family donors. Tzeng CH, Chen PM, Fan S, Liu JH, Chiou TJ, Hsieh RK. Bone Marrow Transplant; 1996 Aug; 18(2):273-7. PubMed ID: 8864434 [Abstract] [Full Text] [Related]
17. Hematopoietic stem cell transplantation for high-risk adult patients with severe aplastic anemia; reduction of graft failure by enhancing stem cell dose. Min CK, Kim DW, Lee JW, Han CW, Min WS, Kim CC. Haematologica; 2001 Mar; 86(3):303-10. PubMed ID: 11255278 [Abstract] [Full Text] [Related]
18. Bone marrow transplantation from matched related donors for patients with Fanconi anemia using low-dose busulfan and cyclophosphamide as conditioning. Torjemane L, Ladeb S, Ben Othman T, Abdelkefi A, Lakhal A, Ben Abdeladhim A. Pediatr Blood Cancer; 2006 Apr; 46(4):496-500. PubMed ID: 16333862 [Abstract] [Full Text] [Related]
19. [Favorable current prognosis after HLA-identical bone marrow transplantation for children with required severe aplastic anemia; evaluation of 30 years of bone marrow transplantation at the Leiden University Medical Center]. van Steekelenburg M, van Weel-Sipman MH, Zwinderman AH, Hoogerbrugge PM, Vossen JM, Egeler RM. Ned Tijdschr Geneeskd; 2002 Aug 17; 146(33):1542-6. PubMed ID: 12212502 [Abstract] [Full Text] [Related]
20. Conditioning with cyclophosphamide/antithymocyte globulin for allogeneic bone marrow transplantation from HLA-matched siblings in children with severe aplastic anemia. Azuma E, Kojima S, Kato K, Matsuyama T, Yamada Y, Kondo N, Sawada H, Hanada M, Shibata T, Tabata N, Watanabe M, Shimono Y, Deguchi T, Umemoto M, Higashikawa M, Kawasaki H, Komada Y, Sakurai M. Bone Marrow Transplant; 1997 Jun 17; 19(11):1085-7. PubMed ID: 9193750 [Abstract] [Full Text] [Related] Page: [Next] [New Search]